Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas

• Published in: Journal of experimental & clinical cancer research Vol. 33; no. 1; p. 34
• Main Authors: Yue, Dongsheng, Li, Hui, Che, Juanjuan, Zhang, Yi, Tseng, Hsin-Hui K, Jin, Joy Q, Luh, Thomas M, Giroux-Leprieur, Etienne, Mo, Minli, Zheng, Qingfeng, Shi, Huaiyin, Zhang, Hua, Hao, Xishan, Wang, Changli, Jablons, David M, He, Biao
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 24.04.2014; BioMed Central
• Subjects: Analysis; Cadherins - metabolism; Carcinoma, Squamous Cell - metabolism; Carcinoma, Squamous Cell - pathology; Cell adhesion & migration; Cell Line, Tumor; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genetic aspects; Hedgehog Proteins - physiology; Humans; Kinases; Lung cancer; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Male; Medical research; Medicine, Experimental; Metastasis; Middle Aged; Respiratory agents; Signal Transduction; Studies; Transcription Factors - physiology; Zinc Finger Protein GLI1; San Francisco California
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/1756-9966-33-34

Squamous cell carcinomas (SCC) account for approximately 30% of non-small cell lung cancer. Investigation of the mechanism of invasion and metastasis of lung SCC will be of great help for the development of meaningful targeted therapeutics. This study is intended to understand whether the activation of Hedgehog (Hh) pathway is involved in lung SCC, and whether activated Hh signaling regulates metastasis through epithelial-mesenchymal transition (EMT) in lung SCC. Two cohorts of patients with lung SCC were studied. Protein expression was examined by immunohistochemistry, Western blot, or immunofluorescence. Protein expression levels in tissue specimens were scored and correlations were analyzed. Vismodegib and a Gli inhibitor were used to inhibit Shh/Gli activity, and recombinant Shh proteins were used to stimulate the Hh pathway in lung SCC cell lines. Cell migration assay was performed in vitro. Shh/Gli pathway components were aberrantly expressed in lung SCC tissue samples. Gli1 expression was reversely associated with the expression of EMT markers E-Cadherin and β-Catenin in lung SCC specimens. Inhibition of the Shh/Gli pathway suppressed migration and up-regulated E-Cadherin expression in lung SCC cells. Stimulation of the pathway increased migration and down-regulated E-Cadherin expression in lung SCC cells. Our results suggested that the Shh/Gli pathway may be critical for lung SCC recurrence, metastasis and resistance to chemotherapy. Inhibition of the Shh/Gli pathway activity/function is a potential therapeutic strategy for the treatment of lung SCC patients.